Your browser doesn't support javascript.
loading
Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging.
Edland, Karin Hestnes; Tjensvoll, Kjersti; Oltedal, Satu; Dalen, Ingvild; Lapin, Morten; Garresori, Herish; Glenjen, Nils; Gilje, Bjørnar; Nordgård, Oddmund.
Afiliación
  • Edland KH; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
  • Tjensvoll K; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
  • Oltedal S; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
  • Dalen I; Section of Biostatistics, Department of Research, Stavanger University Hospital, Norway.
  • Lapin M; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
  • Garresori H; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
  • Glenjen N; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
  • Gilje B; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
  • Nordgård O; Department of Hematology and Oncology, Stavanger University Hospital, Norway.
Mol Oncol ; 17(9): 1857-1870, 2023 09.
Article en En | MEDLINE | ID: mdl-37341038

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / ADN Tumoral Circulante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / ADN Tumoral Circulante Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Mol Oncol Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Noruega Pais de publicación: Estados Unidos